Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

First African child vaccinated with new typhoid conjugate vaccine

Today the University of Maryland School of Medicine's Center for Vaccine Development is proud to be part of vaccine history in Africa.

22 Feb 2018

Pioneering study may pave way for effective painkillers to treat neuropathic pain

A pioneering international study, carried out by the University of Granada, Harvard University, the University of California, Los Angeles, the University of Florida, Laval University and the Jackson Laboratory has conducted an in-depth analysis of the molecular differences between the most common symptoms associated with neuropathic pain.

21 Feb 2018

Researchers create algorithm to reduce spread of infectious diseases

Public outreach campaigns can prevent the spread of devastating yet treatable diseases such as tuberculosis (TB), malaria and gonorrhea. But ensuring these campaigns effectively reach undiagnosed patients, who may unknowingly spread the disease to others, is a major challenge for cash-strapped public health agencies.

21 Feb 2018

Immune history influences person's response to flu vaccine

New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

20 Feb 2018

Loyola Medicine primary care physician offers advice to minimize risk of flu

With widespread flu activity across most of the U.S., avoiding exposure can be difficult, but Loyola Medicine primary care physician Mary Barsanti-Sekhar, MD, offers some advice to minimize the risk.

19 Feb 2018

Researchers develop sensing method for early detection of cancer and diabetes

The use of terahertz waves for biosensing is currently receiving considerable attention. THz waves are able to detect molecular vibrations and rotations, without using labels that can affect the properties of the substances of interest.

19 Feb 2018

FDA approves first treatment to reduce risk of NSCLC progression

The U.S. Food and Drug Administration today approved Imfinzi (durvalumab) for the treatment of patients with stage III non-small cell lung cancer (NSCLC) whose tumors are not able to be surgically removed (unresectable) and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).

18 Feb 2018

Study provides new insights on why healthy children die from flu

With this year's severe flu season, one statistic is especially chilling. Each year, around 50 percent of all children under 5 years old who die from the flu were previously healthy, according to the Centers for Disease Control and Prevention (CDC).

16 Feb 2018

Hand hygiene-intervention practices may reduce risk of infection among nursing home patients

Infection prevention practices centered on hand hygiene protocols can save lives across all healthcare facilities, not just hospital settings.

15 Feb 2018

CAR-T therapy saves life of cancer researcher

About a dozen years ago, Dr. Woodring Wright, a UT Southwestern Professor of Cell Biology, sneezed. It broke one of his vertebrae, the interlocking bones that make up the spinal column.

14 Feb 2018

Muscle plays vital role in regulating heat loss from the hands

In the first study of its kind, Cambridge biological anthropologists have shown that muscle mass is able to predict the rate of heat loss from the hands during severe cold exposure, while body mass, stature and fat mass do not.

14 Feb 2018

Running mitigates negative impacts of chronic stress on the brain, study finds

Most people agree that getting a little exercise helps when dealing with stress. A new BYU study discovers exercise -- particularly running -- while under stress also helps protect your memory.

14 Feb 2018

Flu raises risk of heart attacks

A new study reveals that persons who have been diagnosed with influenza confirmed with laboratory diagnostic tests, are around six times more likely to be admitted for acute myocardial infarction (AMI) or heart attack within a week compared to their risk before they had had the flu.

14 Feb 2018

Kids under two at greater risk of flu related death

Seasonal flu deaths have been studied and it has been seen that since 2009, over the six seasons of flu with the H1N1 strain of the virus, children under 2 years of age are most likely to succumb. Less than one third of these babies that died had received a vaccination against the flu virus.

14 Feb 2018

Excessive screen exposure at age 2 can translate into less healthy lifestyle habits in adolescence

Watching too much television at age 2 can translate into poorer eating habits in adolescence and poorer performance in school, researchers at Université de Montréal's School of Psychoeducation have found.

13 Feb 2018

New findings about fruit fly's body temperature rhythms may help people sleep better

In findings that one day may help people sleep better, scientists have uncovered the first molecular evidence that two anciently conserved proteins in the brains of insects and mammals share a common biological ancestry as regulators of body temperature rhythms crucial to metabolism and sleep.

13 Feb 2018

Opioid users have increased risk of invasive pneumococcal diseases

Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don't use opioids.

13 Feb 2018

New technique enables 3D printing of complex nanoscale metal structures

For the first time, it is possible to create complex nanoscale metal structures using 3-D printing, thanks to a new technique developed at Caltech.

12 Feb 2018

Chinese researchers report first clinical trial based on autologous lung stem cell transplantation

A research team from Tongji University in China have made a breakthrough in human lung regeneration technology. For the first time, researchers have regenerated patients' damaged lungs using autologous lung stem cell transplantation in a pilot clinical trial.

9 Feb 2018

Far-UVC light may offer solution to eradicating airborne flu viruses

Continuous low doses of far ultraviolet C light can kill airborne flu viruses without harming human tissues, according to a new study at the Center for Radiological Research at Columbia University Irving Medical Center.

9 Feb 2018